dehydroepiandrosterone sulfate has been researched along with ATLL in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arima, T; Hanada, S; Iwahashi, M; Nakano, S; Otsuka, M; Takatsuka, Y; Uematsu, T; Uozumi, K | 1 |
1 other study(ies) available for dehydroepiandrosterone sulfate and ATLL
| Article | Year |
|---|---|
Serum dehydroepiandrosterone and DHEA-sulfate in patients with adult T-cell leukemia and human T-lymphotropic virus type I carriers.
Topics: Adrenal Cortex; Adult; Aged; Carrier State; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; HTLV-I Infections; Humans; Immunocompetence; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged | 1996 |